Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
armando.ferrera@uniroma1.it
Armando Ferrera
Specializzando
Struttura:
NON ASSEGNATO
E-mail:
armando.ferrera@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: From Clinical Management to Catheter Ablation Indication
JOURNAL OF CLINICAL MEDICINE
2024
Obesity and Overweight: The “Elephant in the Room” That We can No Longer Ignore: Time to SELECT Treatments
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION
2024
Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2024
Obesity: an overlooked player in cardiological practice and the need for urgent action
EUROPEAN HEART JOURNAL
2024
Differences Between Afro-Caribbean and White Caucasian Olympic Athletes in Plasma Lipids Profile: A Cross-Sectional Single Center Study
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION
2024
Cardiac Adaptation in Power Athletes: Differential Impact of Judo and Weightlifting
JOURNAL OF CLINICAL MEDICINE
2024
Association between Immune Checkpoint Inhibitors and Atherosclerotic Cardiovascular Disease Risk: Another Brick in the Wall
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2024
Cardiomyopathy and Sudden Cardiac Death: Bridging Clinical Practice with Cutting-Edge Research
BIOMEDICINES
2024
SARS-CoV-2 Related Myocarditis. What We Know So Far
JOURNAL OF CLINICAL MEDICINE
2023
Low Perception of Obesity as a Pathological Condition Among Italian Cardiologists
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION
2023
The Emerging Role of Prediabetes and Its Management: Focus on l-Arginine and a Survey in Clinical Practice
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION
2023
Anthracyclines-Induced Cardiac Dysfunction: What Every Clinician Should Know
REVIEWS IN CARDIOVASCULAR MEDICINE
2023
New Insights on the Toxicity on Heart and Vessels of Breast Cancer Therapies
MEDICAL SCIENCES
2022
Comparison of cardiovascular risk scores to predict anthracycline-induced cardiotoxicity in early breast cancer patients
EUROPEAN HEART JOURNAL SUPPLEMENTS
2021
{MICROVASCULAR} {ANGINA} {IS} {ASSOCIATED} {WITH} {SYSTEMIC} {DYSFUNCTION} {OF} {PERIPHERAL} {RESISTANCE} {ARTERIES}
JOURNAL OF HYPERTENSION
2021
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma